147 related articles for article (PubMed ID: 29730230)
21. Vascular endothelial growth factor-C secreted by pancreatic cancer cell line promotes lymphatic endothelial cell migration in an in vitro model of tumor lymphangiogenesis.
Ochi N; Matsuo Y; Sawai H; Yasuda A; Takahashi H; Sato M; Funahashi H; Okada Y; Manabe T
Pancreas; 2007 May; 34(4):444-51. PubMed ID: 17446844
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of Src by microRNA-23b increases the cisplatin sensitivity of chondrosarcoma cells.
Huang K; Chen J; Yang MS; Tang YJ; Pan F
Cancer Biomark; 2017; 18(3):231-239. PubMed ID: 28085008
[TBL] [Abstract][Full Text] [Related]
23. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
[TBL] [Abstract][Full Text] [Related]
24. A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo.
Li XP; Jing W; Sun JJ; Liu ZY; Zhang JT; Sun W; Zhu W; Fan YZ
BMC Cancer; 2015 Jul; 15():527. PubMed ID: 26187792
[TBL] [Abstract][Full Text] [Related]
25. Lipopolysaccharide increases the release of VEGF-C that enhances cell motility and promotes lymphangiogenesis and lymphatic metastasis through the TLR4- NF-κB/JNK pathways in colorectal cancer.
Zhu G; Huang Q; Huang Y; Zheng W; Hua J; Yang S; Zhuang J; Wang J; Ye J
Oncotarget; 2016 Nov; 7(45):73711-73724. PubMed ID: 27713159
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-6 Induces Vascular Endothelial Growth Factor-C Expression via Src-FAK-STAT3 Signaling in Lymphatic Endothelial Cells.
Huang YH; Yang HY; Huang SW; Ou G; Hsu YF; Hsu MJ
PLoS One; 2016; 11(7):e0158839. PubMed ID: 27383632
[TBL] [Abstract][Full Text] [Related]
27. IGFBP7 functions as a potential lymphangiogenesis inducer in non-small cell lung carcinoma.
Zhao W; Wang J; Zhu B; Duan Y; Chen F; Nian W; Sun J; Zhang B; Tong Z; Chen Z
Oncol Rep; 2016 Mar; 35(3):1483-92. PubMed ID: 26706909
[TBL] [Abstract][Full Text] [Related]
28. Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer.
Zhang XH; Huang DP; Guo GL; Chen GR; Zhang HX; Wan L; Chen SY
BMC Cancer; 2008 Jan; 8():4. PubMed ID: 18190720
[TBL] [Abstract][Full Text] [Related]
29. Sphingosine-1-phosphate suppresses chondrosarcoma metastasis by upregulation of tissue inhibitor of metalloproteinase 3 through suppressing miR-101 expression.
Tsai CH; Yang DY; Lin CY; Chen TM; Tang CH; Huang YL
Mol Oncol; 2017 Oct; 11(10):1380-1398. PubMed ID: 28672103
[TBL] [Abstract][Full Text] [Related]
30. COX-2-mediated regulation of VEGF-C in association with lymphangiogenesis and lymph node metastasis in lung cancer.
Liu H; Yang Y; Xiao J; Lv Y; Liu Y; Yang H; Zhao L
Anat Rec (Hoboken); 2010 Nov; 293(11):1838-46. PubMed ID: 20830783
[TBL] [Abstract][Full Text] [Related]
31. miR-181a Targets RGS16 to Promote Chondrosarcoma Growth, Angiogenesis, and Metastasis.
Sun X; Charbonneau C; Wei L; Chen Q; Terek RM
Mol Cancer Res; 2015 Sep; 13(9):1347-57. PubMed ID: 26013170
[TBL] [Abstract][Full Text] [Related]
32. Cellular fibronectin 1 promotes VEGF-C expression, lymphangiogenesis and lymph node metastasis associated with human oral squamous cell carcinoma.
Morita Y; Hata K; Nakanishi M; Omata T; Morita N; Yura Y; Nishimura R; Yoneda T
Clin Exp Metastasis; 2015 Oct; 32(7):739-53. PubMed ID: 26319373
[TBL] [Abstract][Full Text] [Related]
33. Endothelin-1 promotes vascular endothelial growth factor-dependent angiogenesis in human chondrosarcoma cells.
Wu MH; Huang CY; Lin JA; Wang SW; Peng CY; Cheng HC; Tang CH
Oncogene; 2014 Mar; 33(13):1725-35. PubMed ID: 23584483
[TBL] [Abstract][Full Text] [Related]
34. Down-regulation of vascular endothelial cell growth factor-C expression using small interfering RNA vectors in mammary tumors inhibits tumor lymphangiogenesis and spontaneous metastasis and enhances survival.
Chen Z; Varney ML; Backora MW; Cowan K; Solheim JC; Talmadge JE; Singh RK
Cancer Res; 2005 Oct; 65(19):9004-11. PubMed ID: 16204074
[TBL] [Abstract][Full Text] [Related]
35. The role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis.
Tutunea-Fatan E; Majumder M; Xin X; Lala PK
Mol Cancer; 2015 Feb; 14():35. PubMed ID: 25744065
[TBL] [Abstract][Full Text] [Related]
36. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
[TBL] [Abstract][Full Text] [Related]
37. Alternatively activated RAW264.7 macrophages enhance tumor lymphangiogenesis in mouse lung adenocarcinoma.
Zhang B; Wang J; Gao J; Guo Y; Chen X; Wang B; Gao J; Rao Z; Chen Z
J Cell Biochem; 2009 May; 107(1):134-43. PubMed ID: 19241443
[TBL] [Abstract][Full Text] [Related]
38. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
[TBL] [Abstract][Full Text] [Related]
39. Total saponins of panaxnotoginseng promotes lymphangiogenesis by activation VEGF-C expression of lymphatic endothelial cells.
Li J; Chen Y; Zhang L; Xing L; Xu H; Wang Y; Shi Q; Liang Q
J Ethnopharmacol; 2016 Dec; 193():293-302. PubMed ID: 27553977
[TBL] [Abstract][Full Text] [Related]
40. [Lymphangiogenes and location of tumor lymphatic vessels induced by VEGF-C in primary breast carcer].
Huang JH; Li Y; Liu L; Yang HC; Hai J; Tang LL; Hu TH
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):36-9, 51. PubMed ID: 16562672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]